Charles Schwab Investment Management Inc Synlogic, Inc. Transaction History

Charles Schwab Investment Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	BUY	$2.27 - $3.0 $56,750 - $75,000	25,000 New	25,000 $61,000
Q3 2021 Nov 16, 2021	SELL	$2.45 - $4.1 $42,674 - $71,413	-17,418 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.0 - $4.39 $52,254 - $76,465	17,418 New	17,418 $68,000
Q2 2020 Aug 14, 2020	SELL	$1.59 - $2.51 $59,160 - $93,392	-37,208 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$6.27 - $9.48 $23,249 - $35,151	3,708 Added 11.07%	37,208 $339,000
Q3 2018 Nov 13, 2018	BUY	$7.51 - $14.21 $35,297 - $66,787	4,700 Added 16.32%	33,500 $477,000
Q2 2018 Aug 08, 2018	BUY	$9.01 - $13.33 $259,488 - $383,904	28,800 New	28,800 $284,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $105M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.